- Tissue Engineered Ovary
Monica M. Laronda, 2020, Organ Tissue Engineering CrossRef - Müllerian inhibiting substance inhibits an ovarian cancer cell line via β-catenin interacting protein deregulation of the Wnt signal pathway
Sang Ho Park et al, 2017, International Journal of Oncology CrossRef - Engineering a bioprosthetic ovary for fertility and hormone restoration
Monica M. Laronda, 2020, Theriogenology CrossRef - M�llerian inhibiting substance/anti‑M�llerian hormone type II receptor protein and mRNA expression in the healthy and cancerous endometria
Su Kim et al, 2018, Oncology Letters CrossRef - Anti-Müllerian Hormone Expression in Endometrial Cancer Tissue
Marek Gowkielewicz et al, 2019, International Journal of Molecular Sciences CrossRef - The humanized anti-human AMHRII mAb 3C23K exerts an anti-tumor activity against human ovarian cancer through tumor-associated macrophages
Houcine Bougherara et al, 2017, Oncotarget CrossRef - The expression of Müllerian inhibiting substance/anti-Müllerian hormone type II receptor in myoma and adenomyosis
Shin Young Kim et al, 2018, Obstetrics & Gynecology Science CrossRef - Expression of Müllerian-Inhibiting Substance/Anti-Müllerian Hormone Type II Receptor in the Human Theca Cells
Keun Young Cheon et al, 2018, The Journal of Clinical Endocrinology & Metabolism CrossRef - Tissue-Engineered Ovary
Monica M. Laronda, 2021, Organ Tissue Engineering CrossRef - Assessment of Anti-Mullerian Hormone and Anti-Mullerian Hormone Type II Receptor Variants in Women with Repeated Implantation Failures
Yun-xing Fu et al, 2021, Reproductive Sciences CrossRef